Trading Symbol: MCV
TORONTO,
Nov. 8, 2012 /CNW/ - McVicar
Industries Inc. ("McVicar") is pleased to announce that Dr.
Evelyn Su has been appointed to the
Board of Directors of McVicar. Dr. Su is a US citizen and
obtained her Ph.D. in Chemistry from the University of Connecticut, USA. She worked for the
US pharmaceutical giant, Pfizer Inc., in the early 1990s before she
co-founded Sino Lion (USA), Ltd., a chemical company specialized in
personal care and pharmaceutical products with manufacturing
operations in China.
"I am very pleased with the addition of Dr. Su
to our board." commented Dr. Gang Chai, CEO of McVicar. "Her
expertise in the chemical industry and extensive experience in
China will add great value to
McVicar."
The appointment is subject to regulatory
approval.
About McVicar
McVicar Industries Inc., headquartered in Toronto, Canada, is focused on investments and
acquisitions of businesses in China. At present, McVicar has operations in
both electronic components and specialty chemicals in four
operations in China.
This press release contains forward-looking statements which
reflect the Corporation's current expectations regarding future
events. The forward-looking statements involve risks and
uncertainties. Actual results could differ materially from those
projected herein. Although we believe that our expectations are
based on reasonable assumptions, we can give no assurance that our
expectations will materialize.
The TSX Venture Exchange Inc. has not reviewed and does not
accept responsibility for the adequacy or accuracy of this
release.
SOURCE McVicar Industries Inc.